Munich, Directors

Munich Re Directors Bet €82 Million on Their Own Stock as Barclays Trims Price Target

26.05.2026 - 14:11:40 | boerse-global.de

Munich Re executives bought €82M in stock near a 52-week low, while the insurer’s buyback continues. Barclays cut its target to €575, citing pricing headwinds.

Munich Re Directors Bet €82 Million on Their Own Stock as Barclays Trims Price Target - Bild: über boerse-global.de
Munich Re Directors Bet €82 Million on Their Own Stock as Barclays Trims Price Target - Bild: über boerse-global.de

The five-strong buying spree by Munich Re’s board between 12 and 18 May is notable not just for its size, but for its timing. With the stock hovering just above a 52-week low of €467.30, the executives collectively scooped up 174,361 shares worth roughly €82 million — the bulk of it from board member Andrew Buchanan, who acquired 172,728 shares off-exchange at an average €466.83 a pop. Chief financial officer Dr. Achim Kassow, Stefan Golling, Dr. Markus Rieß and Mari-Lizette Malherbe added smaller lots at prices ranging from €470 to €478.89, with Malherbe’s €197,800 purchase closing out the flurry on 18 May.

The insider activity came against a backdrop of institutional support via Munich Re’s existing buyback programme. Between 14 and 21 May the group repurchased nearly 471,000 of its own shares on Xetra at weighted average prices between €466.53 and €484.88. The current tranche, worth up to €900 million or roughly 1.5% of share capital, runs until 21 August 2026, and sits inside a broader €2.25 billion programme that extends to the annual general meeting on 29 April 2027. In total, Munich Re plans to return around €5.3 billion to shareholders this year via buybacks and dividends.

Yet the stock remains under pressure, closing at €474.30 on Tuesday after shedding 0.6% in Stuttgart. That leaves it barely 1.5% above its 12-month floor, with a year-to-date decline of roughly 14%. Barclays acknowledged the valuation challenge: on Tuesday it cut its price target from €606 to €575 while keeping an “Overweight” rating. The British bank sees Munich Re as one of the stronger names among European insurers, alongside ASR, AXA and NN, but the lowered target reflects a more cautious assessment of how much growth the market will price in.

Should investors sell immediately? Or is it worth buying MĂĽnchener RĂĽck?

The caution stems partly from pricing trends in the reinsurance market. At the April renewal season, Munich Re’s written premium volume dropped 18.5% and risk-adjusted pricing fell 3.1%, as the group walked away from business that failed to meet its internal hurdle rates. That discipline helped push first-quarter net profit to €1.714 billion, a 56% year-on-year jump, and kept the combined ratio in property/casualty reinsurance at a healthy 66.8%. Management still targets a full-year net income of €6.3 billion, with the first quarter delivering about 27% of that goal.

Operationally, the near-term outlook is mixed. For the North Atlantic, Munich Re expects 12–13 named storms this year, five to six of hurricane strength — a respite from recent seasons — but warns of elevated typhoon risk in the Pacific. Currency headwinds remain a drag: a strong dollar environment has clipped insurance revenue by nearly €800 million to €15 billion so far this year. Still, the group holds its full-year guidance for group insurance revenue of around €64 billion and the €6.3 billion profit target.

With the next key renewal round due in July, the market will watch whether pricing stability holds — a factor that could remove a key bearish argument. Until then, the stock’s ability to defend support near €467 will depend heavily on how the storm season develops and whether the buyback programme can absorb any further selling pressure. The annual general meeting on 10 June offers the next opportunity for management to make its case to shareholders.

Ad

MĂĽnchener RĂĽck Stock: New Analysis - 26 May

Fresh MĂĽnchener RĂĽck information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated MĂĽnchener RĂĽck analysis...

en | DE0008430026 | MUNICH | boerse | 69420908 |